Brexpiprazole (rexulti) manufacturing plant cost?

I’m not privy to the proprietary cost figures for a brexpiprazole (Rexulti) manufacturing facility, so I can’t give you a precise number. However, I can outline the main factors that drive the cost of building and operating a commercial‑scale pharmaceutical manufacturing plant, and provide a very broad sense of the financial scale that such projects typically involve.

Key cost drivers

Rough cost ranges

• Small‑scale or “pilot” manufacturing unit (e.g., 1–3 kg/day): $10 M–$30 M
• Medium‑scale commercial facility (hundreds of kilograms/day): $30 M–$100 M
• Large‑scale, fully integrated plant (tonnes/day): $100 M–$300 M+

These figures are highly approximate and can vary widely based on:

• Geographic location (US vs. Europe vs. Asia)
• Local labor and construction costs
• Regulatory complexity (e.g., US FDA vs. EMA)
• Desired production capacity and automation level
• Existing infrastructure (e.g., can you lease a pre‑built building or do you need a custom design?)

Additional considerations

• Regulatory approvals: Obtaining GMP certificates and product‑specific licenses can add months to the timeline and millions of dollars in fees.
• Supply chain: Securing raw‑material sources for brexpiprazole (the active pharmaceutical ingredient, or API) can influence the design of the plant and its operating costs.
• Technology choice: Process‑intensive routes (e.g., micro‑reactor chemistry, continuous manufacturing) can reduce operational costs but may raise capital costs.

Bottom line: Building a brexpiprazole manufacturing plant is a substantial investment that typically falls in the tens to hundreds of millions of dollars range, depending on scale, location, and technology. If you need a more precise estimate, you would usually consult with a specialized engineering and consulting firm that can conduct a detailed feasibility study based on your specific requirements.